Showing results (1991-2000 of 2,200) with videos related to

Sort By:
Pageof 220
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 8, 2015
Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the α-synuclein-elicited immune responseAdahir Labrador-Garrido, Marta Cejudo-Guillén, Soumya Daturpalli, et al.
Neurology|October 14, 2009
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR G Miller, C E Jackson, E J Kasarskis, et al.
Neurology|October 14, 2009
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR G Miller, C E Jackson, E J Kasarskis, et al.
International Journal for Equity in Health|September 29, 2018
Disruption as opportunity: Impacts of an organizational health equity intervention in primary care clinicsAnnette J Browne, Colleen Varcoe, Marilyn Ford-Gilboe, et al.
Molecular Genetics and Metabolism|July 4, 2012
Neurotransmitter abnormalities and response to supplementation in SPG11Adeline Vanderver, Davide Tonduti, Sarah Auerbach, et al.
European Journal of Heart Failure|February 16, 2012
Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failureColette E Jackson, Rachel C Myles, Ioannis K Tsorlalis, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumoniaHelen M Marriott, Laura E Jackson, Thomas S Wilkinson, et al.
QJM : Monthly Journal of the Association of Physicians|January 19, 2019
Exercise capacity reflects airflow limitation rather than hypoxaemia in patients with pulmonary arteriovenous malformationsF Gawecki, T Strangeways, A Amin, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancersLindsey N Aubuchon, Deanna H Wong, Natasha M Ramakrishnan, et al.
The American Journal of the Medical Sciences|July 6, 2022
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialMaria I Danila, Dongmei Sun, Lesley E Jackson, et al.
Pageof 220